ghk-cu immunogenicity antibodies topical Frontiers Are We Ready to Measure

Pre-filling syringes reduces effective dose by 58% over 24 hours due to peptide adhesion to syringe walls, which compounds across multi-day protocols and undermines dosing consistency

Serums typically contain 1% to 3% GHK-Cu concentration

[12] What little has appeared since is preclinical and mostly concerns engineered analogues rather than DSIP itself for instance, fusion constructs designed to survive in circulation and cross the blood-brain barrier, tested in chemically-induced insomnia models in mice

It can also be compounded for injection

In general, absorption of the peptide from the stomach into the bloodstream is impossible , and therefore it brings no benefit to improving the functioning of our body